Bastianutto C - Search Results

1

Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer.

Shi W, Alajez NM, Bastianutto C, Hui AB, Mocanu JD, Ito E, Busson P, Lo KW, Ng R, Waldron J, O'Sullivan B, Liu FF. Shi W, et al. Among authors: bastianutto c. Int J Cancer. 2010 May 1;126(9):2036-48. doi: 10.1002/ijc.24880. Int J Cancer. 2010. PMID: 19739117 Free article.

2

Targeted depletion of BMI1 sensitizes tumor cells to P53-mediated apoptosis in response to radiation therapy.

Alajez NM, Shi W, Hui AB, Yue S, Ng R, Lo KW, Bastianutto C, O'Sullivan B, Gullane P, Liu FF. Alajez NM, et al. Among authors: bastianutto c. Cell Death Differ. 2009 Nov;16(11):1469-79. doi: 10.1038/cdd.2009.85. Epub 2009 Jul 3. Cell Death Differ. 2009. PMID: 19575017

3

Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer.

Chia MC, Leung A, Krushel T, Alajez NM, Lo KW, Busson P, Klamut HJ, Bastianutto C, Liu FF. Chia MC, et al. Among authors: bastianutto c. Clin Cancer Res. 2008 Feb 15;14(4):984-94. doi: 10.1158/1078-0432.CCR-07-0828. Clin Cancer Res. 2008. PMID: 18281530

4

Combination bcl-2 antisense and radiation therapy for nasopharyngeal cancer.

Yip KW, Mocanu JD, Au PY, Sleep GT, Huang D, Busson P, Yeh WC, Gilbert R, O'Sullivan B, Gullane P, Bastianutto C, Liu FF. Yip KW, et al. Among authors: bastianutto c. Clin Cancer Res. 2005 Nov 15;11(22):8131-44. doi: 10.1158/1078-0432.CCR-05-1266. Clin Cancer Res. 2005. PMID: 16299246

5

Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling.

Shi W, Bastianutto C, Li A, Perez-Ordonez B, Ng R, Chow KY, Zhang W, Jurisica I, Lo KW, Bayley A, Kim J, O'Sullivan B, Siu L, Chen E, Liu FF. Shi W, et al. Among authors: bastianutto c. Int J Cancer. 2006 Nov 15;119(10):2467-75. doi: 10.1002/ijc.22107. Int J Cancer. 2006. PMID: 16858677 Free article.

6

Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.

Yip KW, Shi W, Pintilie M, Martin JD, Mocanu JD, Wong D, MacMillan C, Gullane P, O'Sullivan B, Bastianutto C, Liu FF. Yip KW, et al. Among authors: bastianutto c. Clin Cancer Res. 2006 Oct 1;12(19):5726-32. doi: 10.1158/1078-0432.CCR-06-0571. Clin Cancer Res. 2006. PMID: 17020977

7

Increased efficiency for performing colony formation assays in 96-well plates: novel applications to combination therapies and high-throughput screening.

Katz D, Ito E, Lau KS, Mocanu JD, Bastianutto C, Schimmer AD, Liu FF. Katz D, et al. Among authors: bastianutto c. Biotechniques. 2008 Feb;44(2):ix-xiv. doi: 10.2144/000112757. Biotechniques. 2008. PMID: 18422490 Free article.

8

Potential use of cetrimonium bromide as an apoptosis-promoting anticancer agent for head and neck cancer.

Ito E, Yip KW, Katz D, Fonseca SB, Hedley DW, Chow S, Xu GW, Wood TE, Bastianutto C, Schimmer AD, Kelley SO, Liu FF. Ito E, et al. Among authors: bastianutto c. Mol Pharmacol. 2009 Nov;76(5):969-83. doi: 10.1124/mol.109.055277. Epub 2009 Aug 4. Mol Pharmacol. 2009. PMID: 19654225

9

Imaging the Modulation of Adenoviral Kinetics and Biodistribution for Cancer Gene Therapy.

Mocanu JD, Yip KW, Alajez NM, Shi W, Li JH, Lunt SJ, Moriyama EH, Wilson BC, Milosevic M, Lo KW, van Rooijen NV, Busson P, Bastianutto C, Liu FF. Mocanu JD, et al. Among authors: bastianutto c. Mol Ther. 2007 May;15(5):921-929. doi: 10.1038/mt.sj.6300119. Epub 2016 Dec 7. Mol Ther. 2007. PMID: 28182894

10

Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent.

Yip KW, Ito E, Mao X, Au PY, Hedley DW, Mocanu JD, Bastianutto C, Schimmer A, Liu FF. Yip KW, et al. Among authors: bastianutto c. Mol Cancer Ther. 2006 Sep;5(9):2234-40. doi: 10.1158/1535-7163.MCT-06-0134. Mol Cancer Ther. 2006. PMID: 16985057

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page